nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A cost-benefit analysis of the immunisation of children against respiratory syncytial virus (RSV) using the English Hospital Episode Statistics (HES) data set
|
Thomas, Gareth |
|
2015 |
19 |
2 |
p. 177-187 |
artikel |
2 |
Association between cultural distance and migrant self-rated health
|
Detollenaere, Jens |
|
2017 |
19 |
2 |
p. 257-266 |
artikel |
3 |
Beyond QALYs: Multi-criteria based estimation of maximum willingness to pay for health technologies
|
Nord, Erik |
|
2017 |
19 |
2 |
p. 267-275 |
artikel |
4 |
Cost-effectiveness of vedolizumab compared with infliximab, adalimumab, and golimumab in patients with ulcerative colitis in the United Kingdom
|
Wilson, Michele R. |
|
2017 |
19 |
2 |
p. 229-240 |
artikel |
5 |
Do healthcare tax credits help poor-health individuals on low incomes?
|
Di Novi, Cinzia |
|
2017 |
19 |
2 |
p. 293-307 |
artikel |
6 |
Improving risk equalization using information on physiotherapy diagnoses
|
Eijkenaar, Frank |
|
2017 |
19 |
2 |
p. 203-211 |
artikel |
7 |
New findings from the time trade-off for income approach to elicit willingness to pay for a quality adjusted life year
|
Attema, Arthur E. |
|
2017 |
19 |
2 |
p. 277-291 |
artikel |
8 |
Systematic review of model-based economic evaluations of heart valve implantations
|
Huygens, Simone A. |
|
2017 |
19 |
2 |
p. 241-255 |
artikel |
9 |
The economic burden of diabetes to French national health insurance: a new cost-of-illness method based on a combined medicalized and incremental approach
|
Lagasnerie, Grégoire de |
|
2017 |
19 |
2 |
p. 189-201 |
artikel |
10 |
The impact of physician-level drug budgets on prescribing behavior
|
Fischer, Katharina Elisabeth |
|
2017 |
19 |
2 |
p. 213-222 |
artikel |
11 |
The impact of post-procedural complications on reimbursement, length of stay and mechanical ventilation among patients undergoing transcatheter aortic valve implantation in Germany
|
Kaier, Klaus |
|
2017 |
19 |
2 |
p. 223-228 |
artikel |
12 |
The use of budget impact analysis in the economic evaluation of new medicines in Australia, England, France and the United States: relationship to cost-effectiveness analysis and methodological challenges
|
Ghabri, Salah |
|
2017 |
19 |
2 |
p. 173-175 |
artikel |